ImmunoBrain Checkpoint awarded Alzheimer’s Association grant to support Phase I trial investigating novel immunotherapeutic approach to treat Alzheimer’s disease ImmunoBrain Checkpoint awarded Alzheimer’s Association grant to support Phase I trial investigating novel immunotherapeutic approach to treat Alzheimer’s disease NEW YORK, Tuesday September 1, 2020...

Northwestern IP Professor David Schwartz to Speak at The John Marshall Law School on Patent Litigation CHICAGO, Aug. 19, 2016 (GLOBE NEWSWIRE) -- David L. Schwartz, a Northwestern University law professor, will speak at The John Marshall Law School in Chicago on August 31 about patent litigation. The...